Navigation Links
Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
Date:11/15/2013

LAVAL, Quebec, Nov. 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has priced its previously announced offering of 5.625% senior unsecured notes due 2021 (the "Notes"). The Company increased the offering to $900 million from $850 million aggregate principal amount of the Notes. The offering is expected to close on or about December 2, 2013.  The net proceeds of the offering is expected to be used to finance the redemption of all of the Company's wholly-owned subsidiary's, Valeant Pharmaceuticals International's, outstanding 6.50% Senior Notes due 2016, as well as to pay fees and expenses related to the foregoing.  Concurrently with the pricing of this offering, Valeant Pharmaceuticals International has irrevocably called for redemption $450 million aggregate principal amount of its 6.50% Senior Notes due 2016.  On the closing date of this offering, Valeant Pharmaceuticals International intends to irrevocably call for redemption the remaining $465.5 million aggregate principal amount of its 6.50% Senior Notes due 2016 and use the remaining net proceeds from this offering, together with approximately $50 million of either cash on hand or from borrowings under the Company's revolving credit facility, or a combination thereof, to pay the redemption price of the notes called.

The Notes will be guaranteed by each of the Company's subsidiaries that is a guarantor of the Company's senior secured credit facilities.

The Notes will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
2. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
3. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
4. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
5. Valeant Pharmaceuticals Announces Continuance
6. Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results
7. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
8. Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
9. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
10. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
11. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 /CNW/ - Sante Medical Hair ... Procedure for hair transplantation. The ARTAS ... safely and effectively extracts hair for transplantation. This ... virtually undetectable results, with no linear scar. ... the ease of hair restoration surgery." says Dr. ...
(Date:3/3/2015)... March 3, 2015  Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it ... Wednesday, March 11, 2015, in Miami ... and Chief Executive Officer, will speak at 1:05 PM ... fireside chat format, and no formal materials will be ...
(Date:3/3/2015)...  The eleventh annual Tucson Symposium will be held ... research scientists, academics, oncologists and pathologists will gather to ... new outcomes in patient treatments that may significantly affect ... Ventana Medical Systems, Inc. (Ventana), a member of ... at the Hilton El Conquistador in Tucson, ...
Breaking Medicine Technology:No linear scar. Permanent results. 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
(Date:3/3/2015)... Dallas plastic surgeon , Dr. Rod J. ... Rhinoplasty Symposium, to be held March 6th to March ... by plastic surgeons and otolaryngologists from around the world, ... current topics, emerging techniques, best practices, and advances in ... The symposium will cover a diverse array of rhinoplasty ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 March 3, 2015, ... the 200th episode. The episode was a unique one, not ... season, but because it featured two men who were both ... accident. At the beginning of the episode, Deierlein said to ... on my radio show, but I’m very excited that you ...
(Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Venato, ... organizations, announced that their flagship software solution now ... information to be uploaded to the National Healthcare ... and Medicaid Services (CMS) require that hospitals submit ... NHSN no later than May 15 for each ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2
... , BOTHELL, Wash., Sept. 18 ... today that on September 15, 2009, the NYSE Amex LLC ... to its previously disclosed listing deficiency as set forth in ... relates to the Company,s failure to maintain stockholder,s equity of ...
... , , , ... Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of ... 57, has embarked on his third annual "Grandpa,s Road Trip" with ... the NxStage System One provides Mr. Wells the opportunity to fit ...
... , , , , ... hip abnormalities, combined with advances in diagnostic imaging techniques and minimally ... chronic, misdiagnosed hip pain. , , Increasingly, ... of degenerative hip disease, get patients back to their chosen activities ...
... , Statement of Andy Stern, President ... Andy Stern, President of the Service Employees International ... wing extremists to silence working families by attacking progressive individuals and ... moment of profound change for this country -- from kitchen tables ...
... Calif., Sept. 18 Solta Medical, Inc. (Nasdaq: SLTM ... that it will present at the Maxim Group Growth Conference to ... New York Hotel in New York, NY. The Company,s presentation ... Stephen J. Fanning, Chairman, President and Chief Executive Officer, will ...
... CHICAGO, Sept. 18 As economic, social and political ... state,s leading provider of addiction treatment services is expanding its ... afford expensive clinics but also fail to qualify for government-funded ... a 41-year-old non-profit organization, serves more than 29,000 patients in ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 2Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 2Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 4Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 5Health News:Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs; SEIU Members and Other Working Americans Will Continue to Speak Out For the America We Believe In 2Health News:Solta Medical to Present at the Maxim Group Growth Conference 2Health News:Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers 2
Topics include: ECG reading, ACLS (all the latest protocols and pearls), CHF, acute MI, cardiac testing, palpitations, pericarditis, arrhythmias, murmurs, athletes, valvular disease, endocarditis, sy...
Cardiology Core Curriculum fills the gap between the preclinical pathophysiology texts and specialist volumes aimed at cardiologists. It covers clinical cardiology for medical students, cardiology tr...
... published by Unbound Medicine ... resource that combines evidence-based ... edge technology. It offers ... specifically engineered to provide ...
This electronic survival guide provides all the essential information that every surgery intern needs from Day 1 on the wards....
Medicine Products: